• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Device Problem Obstruction of Flow (2423)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 01/30/2023
Event Type  Injury  
Event Description
It was reported that acute stent thrombosis occurred.A 3.50 x 20mm synergy drug-eluting stent was implanted on an unspecified date.Catheterization was performed which revealed acute stent thrombosis.It was noted that the patient did not get dual antiplatelet therapy, and was only on aspirin and another medication so, it was thought that it was an anti-coagulation issue.There were no further patient complications nor injuries reported.
 
Event Description
It was reported that acute stent thrombosis occurred.A 3.50 x 20mm synergy drug-eluting stent was implanted on an unspecified date.Catheterization was performed which revealed acute stent thrombosis.It was noted that the patient did not get dual antiplatelet therapy, and was only on aspirin and another medication so, it was thought that it was an anti-coagulation issue.There were no further patient complications nor injuries reported.It was further reported that angiogram led to the discovery of stent thrombosis.The 95% stenosed target lesion was located in the proximal right coronary artery.The physician tried to perform percutaneous coronary intervention (pci) to resolve the event but was unsuccessful crossing the previously placed stent.The patient was going to be transferred to another hospital to perform intervention.The patient had no symptoms related to the issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16404598
MDR Text Key309860518
Report Number2124215-2023-05913
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-